Innate Pharma SA Current Assets
Innate Pharma SA (IPHA) had Current Assets of EUR 46.71 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2026-04-01
- 2025-12-31: Current Assets 46.71M EUR.
- 2025-06-30: Current Assets 64.98M EUR.
- 2024-12-31: Current Assets 85.74M EUR.
- 2024-06-30: Current Assets 111.59M EUR.
| Period end | Current Assets | Current Assets as first filed |
|---|---|---|
| 2025-12-31 | 46.71M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 64.98M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 85.74M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 111.59M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 148.01M EUR 20-F · filed 2026-04-01 | 148.01M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 144.46M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 139.83M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 171.80M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 138.26M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 129.69M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 173.45M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 237.60M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 319.64M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 137.52M EUR 20-F · filed 2020-04-24 |